In a special edition of Immunity, focussed on the tumour immune microenvironment, Prof Pollard and Dr. Esra Güç publish an article entitled Redefining macrophage and neutrophil biology in the metastatic cascade. The cover image depicts the various roles of macrophages, neutrophils, and their progenitors in the metastatic cascade, drawn by current and ex-members of the Pollard lab.
Author: edgover
Macomics Senior Scientist, Dr. Martha Lopez-Yrigoyen to Chair sessions at 2021 Tumour myeloid Microenvironment Directed Therapeutics Summit
Macomics is pleased to announce that Dr Lopez-Yrigoyen will Chair sessions at 2021 Tumour myeloid Microenvironment Directed Therapeutics Summit. She has extensive experience in genetic engineering/programming of human induced pluripotent stem cell derived macrophages and her sessions will highlight the advances and challenges in therapeutically targeting tumour-resident myeloid populations. The conference will be held virtually on March 16 – 18, 2021.
Macomics secures £3.2 million seed funding
Macomics Ltd, an immuno-oncology company with world-leading expertise in macrophage biology, launches today with a £3.2 million seed financing round led by transatlantic VC Epidarex Capital, with the Scottish Investment Bank, the investment arm of Scottish Enterprise, also investing.